Poseida Therapeutics Inc (PSTX)
9.42
-0.09
(-0.95%)
USD |
NASDAQ |
Dec 27, 16:00
9.425
0.00 (0.00%)
After-Hours: 20:00
Poseida Therapeutics Research and Development Expense (Annual): 156.77M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Galectin Therapeutics Inc | 32.13M |
| Revance Therapeutics Inc | 79.41M |
| Sage Therapeutics Inc | 356.24M |
| Alector Inc | 192.12M |
| Phathom Pharmaceuticals Inc | 49.90M |